Grown Rogue International (GRUSF) Income from Non-Controlling Interests (2019 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Income from Non-Controlling Interests of -$488826.0 in Q1 2026, up 100.0% quarter-over-quarter from -$321.7 billion in Q4 2025, and down 239.26% on a YoY basis from $351029.0 in Q1 2025.

Grown Rogue International (GRUSF) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends

Grown Rogue International's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at -$488826.0 for Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests fell 239.26% year-over-year to -$488826.0; the TTM figure through Mar 2026 stood at -$182.1 billion (down 29.91% YoY), while the FY2025 annual figure was -$1.5 million, down 5450.36% from the prior year.
  • Income from Non-Controlling Interests was -$488826.0 for Q1 2026 at Grown Rogue International, up from -$321.7 billion in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $139.6 billion in Q3 2025 to a low of -$321.7 billion in Q4 2025.
  • Historically, Income from Non-Controlling Interests has averaged -$21.5 billion across 5 years, with a median of $30728.0 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests soared 11432.01% in 2022, then sank 915246585.72% in 2024.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $564607.0 in 2022, then sank by 94.76% to $29607.0 in 2023, then tumbled by 915246585.72% to -$271.0 billion in 2024, then fell by 18.72% to -$321.7 billion in 2025, then jumped by 100.0% to -$488826.0 in 2026.
  • The last three Income from Non-Controlling Interests figures came in at -$488826.0 (Q1 2026), -$321.7 billion (Q4 2025), and $139.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Grown Rogue International - - 3.96 Mn -488,826.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -488,826.00
Dec 31, 2025 -321.70 Bn
Sep 30, 2025 139.57 Bn
Jun 30, 2025 99,131.00
Mar 31, 2025 -144,088.00
Dec 31, 2024 -270.98 Bn
Sep 30, 2024 130.78 Bn
Jun 30, 2024 80,039.42
Mar 31, 2024 30,728.00
Dec 31, 2023 29,607.00
Oct 31, 2023 210,129.00
Jul 31, 2023 119,093.00
Apr 30, 2023 -867.00
Jan 31, 2023 -339,408.00
Jan 31, 2022 564,607.00
Oct 31, 2021 1.12 Mn
Jul 31, 2021 283,126.00
Apr 30, 2021 -15,306.00
Jan 31, 2021 4,896.00
Oct 31, 2020 -38,608.00